Omitac-20 capsule is indicated for gastro esophageal reflux disease (GERD) including reflux esophagitis, acid reflux disease, duodenal ulcer, gastric ulcer, Helicobacter pylori (H. Pylori) eradication in peptic ulcer disease, Zollinger-Ellison Syndrome (ZES) and for the treatment of NSAID - induced gastric ulcers & duodenal ulcer.

DOSAGE & ADMINISTRATION: Duodenal ulcer: 20 mg daily before a meal. Gastric ulcer: 40 mg daily before a meal for 4 to 8 weeks. Erosive esophagitis: 20 mg daily before a meal. This dosage may be increased to 40 mg per day. Zollinger-Ellison Syndrome (ZES): Initial: 60 mg orally daily. Maintenance doses up to 120 mg 3 times a day. Daily doses greater than 80 mg should be divided. Gastroesophageal Reflux Disease (GERD): Initial: 20 mg daily before a meal for 4 to 8 weeks. This dosage may be increased to 40 mg per day if needed. SIDE EFFECT: Omeprazole is well tolerated. Nausea, diarrhoea, dizziness and headache have been stated to be generally mild and transient and not requiring a reduction in dosage. CONTRAINDICATIONS: There are no known contraindications to the use of Omeprazole. When gastric ulcer is suspected, the possibility of malignancy should be excluded before treatment with Omeprazole is instituted as treatment may alleviate symptoms and delay diagnosis. PRECAUTION: Symptomatic response to therapy with Omeprazole does not preclude the presence of gastric malignancy. OVERDOSAGE: Symptoms were transient and no serious clinical outcome has been reported with Omeprazole overdose. Omeprazole is extensively bound with protein and is therefore not readily dialyzable. In the event of overdose treatment should be symptomatic and supportive. USE IN PREGNANCY AND LACTATION: Result from three prospective epidemiological studies indicate no adverse effects of Omeprazole on pregnancy or on the health of the fetus/newborn child. Omeprazole can be used during pregnancy. Omeprazole is excreted in breast milk but is not likely to influence the child when therapeutic doses are used.